Cargando…
The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer
Ovarian cancer is currently one of the most common malignant tumors in females with poor survival rates around the world, killing about 200,000 women each year. Although great progress has been made in treatment, most patients receiving first-line therapy experience tumor recurrence. The tumor micro...
Autores principales: | Zheng, Aiping, Wei, Yuhao, Zhao, Yunuo, Zhang, Tao, Ma, Xuelei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577001/ https://www.ncbi.nlm.nih.gov/pubmed/36268019 http://dx.doi.org/10.3389/fimmu.2022.1013506 |
Ejemplares similares
-
Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatment
por: Wei, Yuhao, et al.
Publicado: (2022) -
The Immune Subtype Contributes to Distinct Overall Survival for Ovarian Cancer Patients With Platinum-Based Adjuvant Therapy
por: Li, Yueyi, et al.
Publicado: (2022) -
Myeloid-Derived Suppressor Cells Promote Metastasis in Breast Cancer After the Stress of Operative Removal of the Primary Cancer
por: Ma, Xuelei, et al.
Publicado: (2019) -
Macrophages Promote Ovarian Cancer-Mesothelial Cell Adhesion by Upregulation of ITGA2 and VEGFC in Mesothelial Cells
por: Cho, Seung-Kye, et al.
Publicado: (2023) -
The role of interferons in ovarian cancer progression: Hinderer or promoter?
por: Liu, Taiqing, et al.
Publicado: (2022)